For the week ending July 27, 2.2% of emergency department visits at U.S. hospitals involved patients who tested positive for COVID-19, marking a 12.1% jump from the previous week. For the week of Aug. 10-16, the rates stood at 2.4%.
Southeastern states are still showing the highest percentage of COVID-19 visits, with most ranging between 3% and 4.4%.
Here are four more COVID-19 updates:
1.The FDA is slated to sign off on two updated COVID-19 vaccines this month targeting the KP.2 strain, CNN reported Aug. 18. The mRNA vaccines are made by Moderna and Pfizer/BioNTech. When the vaccines would be approved has not been announced, nor is it known if Novavax’s updated shot, which targets JN.1 strain, would also be approved.
2. Springfield, Mass.-based Baystate Health facilities are reinstating masking mandates amid the rise of COVID-19 cases, Western Mass News reported Aug. 17.
3. The CDC now considers COVID-19 to be endemic, though not all health experts agree with this classification. Some epidemiologists argue COVID-19 is still too unpredictable to be labeled as endemic.
4. COVID-19 deaths fell 68.9% from 2022 to 2023 — dropping from the fourth-leading cause of death to the 10th, the CDC said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
